Physician
Allergy & Immunology
Dr. Vera S. Byers, MD
Doctor Vera S. Byers, MD works in the field of Allergy & Immunology. He went to medical school at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine Vera S. Byers is a published doctor and has 60 publications published. The lastest was: 'The relationship between premorbid life-style and wandering behaviors in institutionalized people with dementia.'
Publications
- Measles virus infection and vaccination: potential role in chronic illness and associated adverse events.
- Predictive risk factors associated with stroke patient falls in acute care settings.
- The relationship between premorbid life-style and wandering behaviors in institutionalized people with dementia.
- Effects of an anti-CD5 immunoconjugate (CD5-plus) in recent onset type I diabetes mellitus: a preliminary investigation. The CD5 Diabetes Project Team.
- Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin.
- A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.
- A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.
- Suppression of urushiol-induced delayed-type hypersensitivity responses in mice with serum IgG immunoglobulin from human hyposensitized donors.
- Induction of tolerance to poison ivy urushiol in the guinea pig by epicutaneous application of the structural analog 5-methyl-3-n-pentadecylcatechol.
- Monoclonal antibody 45-2D9 conjugated to the A chain of ricin is specifically toxic to c-Ha-ras-transfected NIH 3T3 cells expressing gp74.
- Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma.
- Influence of chemical reactivity of urushiol-type haptens on sensitization and the induction of tolerance.
- Regulation of murine contact sensitivity to urushiol components by serum factors.
- Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents.
- Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
- Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
- Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody.
- Environmental illness: a disorder of immune regulation.
- Monoclonal antibodies in cancer treatment.
- Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
- Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.
- Monoclonal antibody immunoconjugates for cancer treatment.
- A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
- Monoclonal antibody 791T/36 immunoconjugates for cancer treatment.
- Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.
- Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA.
- Monoclonal antibody targeting of anti-cancer agents.
- Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease.
- A phase I/II study of trichosanthin treatment of HIV disease.
- Monoclonal antibodies: new agents for cancer detection and targeted therapy.
- Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action.
- Rationale for clinical use of immunotoxins in cancer and autoimmune disease.
- Trichosanthin treatment of HIV disease.
- Multiple chemical sensitivities: a practicing clinician's point of view. Clinical and immunologic research findings.
- Targeted kill: from umbrellas to monoclonal antibodies.
- In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.
- In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
- Transfer of contact sensitivity to beryllium using dialyzable leukocyte extracts (transfer factor).
- Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors.
- Suppression of antibody responses to ricin A chain (RTA) by monoclonal anti-RTA antibodies.
- Induction of persistent tolerance to urushiol in humans.
- Regiospecific attack of nitrogen and sulfur nucleophiles on quinones derived from poison oak/ivy catechols (urushiols) and analogues as models for urushiol-protein con...
- Contact sensitivity to urushiol: role of covalent bond formation.
- Cellular interactions modulating host resistance to tumours.
- Antigens on naturally occurring animal and human tumors detected by monoclonal antibodies.
- Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.
- Antibodies against osteosarcoma and colon cancer.
- Induction of suppressor T cells for lymph node cell proliferation after contact sensitization of mice with a poison oak urushiol component.
- Induction of antigen specific hyposensitization to poison oak in sensitized adults.
- A murine model system for contact sensitization to poison oak or ivy urushiol components.
- Circulating immune complexes in patients with bone tumours.
- Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.
- Measurement of murine IgE antibody responses to dust mite allergens by in vitro assay.
- Neurological reactions in HIV-infected patients treated with trichosanthin.
- A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents.
- Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water sup...
- Monoclonal antibodies and immunoconjugates for cancer treatment.
- Therapeutic strategies with monoclonal antibodies and immunoconjugates.
- Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine.
Schools
University of California At San Francisco
University Calif Davis
Pacific Med Center
Uc San Francisco
Ucsf Med Center
Doctors Specialties
- Internal Medicine
- Allergy
- Immunology
Accepted Insurances
- Medicare Advantage PFFS
- Medicare MCR
Education
-
UCSF -
University of California San Francisco School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Morton J. Cowan, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Russell E. Leong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurence Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane W. Wara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey M. Davidson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rupali Das, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bhavna A. Kasturia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerold M. Lowenstein, MD |
|
|
Dr. Shaun J. Young, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul B. Aronowitz, MD |
|
|
Dr. Yoon T. Kwon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hoang H. Pham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily A. Welsh, MD |
|
|
Dr. Thao H. Tran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zhen Lu, MD |